study
investigated
visual
defects
associated with
antiepileptic drug vigabatrin
VGB
people
epilepsy
grouped
antiepileptic drug therapy
current
no exposure
VGB
Groups
age
gender
seizure
frequency
patients
assessment
electrophysiological function
wide-field multifocal electroretinography
conventional
visual field testing
static perimetry
Bilateral
visual field constriction
patients
VGB
patients
VGB
patients
no exposure
VGB
Assessment
retinal function
abnormal
responses
current
VGB
users
prior
VGB
users
patients
exposure to
VGB
Bilateral
visual field abnormalities
treated
epilepsy
population
drug history
Assessment
conventional
static perimetry
sensitive
retinal
toxicity
associated with
VGB
